Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fjji, 2021

Stephanie J. Curtis; Abdul W. Shah; Ana Ratu; Donald J. Wilson; Philip C. Hill; Phil Hulcome; Cathy Gaylard; Daniel Faktaufon; Talica Cabemaiwai; Isireli Rabukawaqa; Tevita Qoriniasi; Akesh Narayan; Susana Nakalevu; Pablo Romakin; Jemesa Tudravu; James Fong; Nick Walsh

doi:10.3201/eid2901.221514

Back

Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fjji, 2021

Letter/Communication

Open access

Peer reviewed

Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fjji, 2021

Stephanie J. Curtis, Abdul W. Shah, Ana Ratu, Donald J. Wilson, Philip C. Hill, Phil Hulcome, Cathy Gaylard, Daniel Faktaufon, Talica Cabemaiwai, Isireli Rabukawaqa, …

Emerging infectious diseases, Vol.29(1), pp.226-228

01/01/2023

DOI: https://doi.org/10.3201/eid2901.221514

Handle:

https://hdl.handle.net/10523/49422

Abstract

Epidemics

Fiji

Statistics

SARS-CoV-2

seroprevalence

COVID-19

During November–December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8–70 years of age were 95.5% (95% CI 93.4%–97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.

Files and links (2)

pdf

22-1514264.23 kBDownload View

Published (Version of record)CC0 V1.0, Open Access

url

https://doi.org/10.3201/eid2901.221514View

Published (Version of record)CC0 V1.0, Open

Metrics

1 Record Views

See more details

Details

Record Identifier: 9926820345901891
Title: Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fjji, 2021
Creators: Stephanie J. Curtis
Abdul W. Shah
Ana Ratu
Donald J. Wilson
Philip C. Hill
Phil Hulcome
Cathy Gaylard
Daniel Faktaufon
Talica Cabemaiwai
Isireli Rabukawaqa
Tevita Qoriniasi
Akesh Narayan
Susana Nakalevu
Pablo Romakin
Jemesa Tudravu
James Fong
Nick Walsh
Publication Details: Emerging infectious diseases, Vol.29(1), pp.226-228
Academic Unit: Centre for International Health
Publisher: Centers for Disease Control and Prevention (CDC)
Grant note: Australian Department of Foreign Affairs and Trade through the National Critical Care and Trauma Response Centre
Date published ; e-published: 01/01/2023
Copyright: This work was first published in Emerging Infectious Diseases (CDC), a publication of the U.S. Government. This publication is in the public domain, CC0 1.0 Universal (https://creativecommons.org/publicdomain/zero/1.0/), and the authors and publication have waived all of their rights to the work worldwide under copyright law, including all related and neighboring rights, to the extent allowed by law. This permits copying, modification, distribution and performing of the work, for any purposes, without seeking permission. Use of this work should be properly cited.
Language: English
Resource Type ; Subtype: Letter/Communication